chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented with fever and hypoxia - determined to be SIRS.  No infectious source found. Other symptoms included confusion, lethargy, aches, headache and fever.
PATIENT CAME IN TO CLINIC TO RECEIVE MODERNA BIVALENT BOOSTER VACCINE AND FLU VACCINE SAME DAY. BOOSTER VACCINE WAS GIVEN ON LEFT DELTOID AND FLU VACCINE WAS GIVEN ON RIGHT DELTOID. PATIENT DID NOT EXPERIENCE PAIN ON NEITHER ARM RIGHT AWAY. HE FIRST STARTED FEELING PAIN ON HIS LEFT ARM NEAR VACCINE SITE ON 10/27/2022 IN THE EVENING AFTER HIS SHIFT WAS DONE. HE REPORTS PAIN MORE WHEN HE IS AT REST, WHEN HE IS AT WORK AND IN MOVEMENT, HE FEELS NO PAIN. PAIN ALSO COMES AND GOES SINCE IT INICIALLY STARTED.
Pt recv vax on 10/14/97; on same day pt exp fever, nausea, headache, cold feeling; tx=non-aspirin reliever
APPROXIMATELY 9PM ON 9/22/22 IN THE EVENING AFTER COVID 19 BOOSTER SHOT, PATIENT, SUFFERED A BRAIN BLEED (STROKE). SUBSEQUENT TO HOSPITALIZATION, PATIENT TRANSFERRED TO REHABILITATION FOR 32 DAYS THEN HOME CARE FOR 10 DAYS, NOW IN OUTPATIENT PHYSICAL, SPEECH, AND OCCUPATIONAL THERAPY.
This case was reported by a consumer (subject) and described the occurrence of peanut allergy in a 64-year-old male subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 1 November 2012 the subject received a dose of FLUARIX (unknown details). In November 2012, less than one month after vaccination with FLUARIX, the subject experienced peanut allergy. The subject stated he "received the flu vaccine and developed a peanut allergy." The subject stated that the immunization series was not discontinued. At the time of reporting the event was unresolved.
The day after the vaccine I developed red welts all over my upper arm, both on top and underneath,  around and on the injection site.  They were sore and hot to the touch.  As soon as I noticed I took Benadryl and called a nurse since it was after dr office hours.  The next day,  I called the doctor and they advised me to continue to take Benadryl the next  2 days until the swelling, welts and redness subsided.
crying lasting for >24hr;pt fussy >72hr;mom states was pale immed p/shots;
Fever of 102.5 on 4/13, fever of 101.3 on 4/14, fever of 103.6 on 4/15.
h/a, bone and body pain, fever, Numbness tongue , pins and needles in rt arm.
Pain was stabbing and burning/Body ache; Shingles; Left lower shoulder blade pain; Stabbing pain that was radiating around her rib cage to her left breast; High fever/Fever was 102, fluctuated from 102-103; Nausea; Freezing/Chills; Shaking/Trembling; Burning up; Patient received 1st dose on 07Jan2021 and the 2nd dose 18 days after on 24Jan2021; Patient received 1st dose on 07Jan2021 and the 2nd dose 18 days after on 24Jan2021; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: BL9262), dose 2, via an unspecified route of administration on 24Jan2021 (at the age of 42-years-old) as 2nd dose, single for COVID-19 immunization. Medical history included chickenpox when she was a kid. The patient has no concomitant medications. The patient received the 1st dose of BNT162B2 (lot number: EK4176) on 07Jan2021 for COVID-19 immunization. The patient had no prior vaccinations within 4 weeks of the administration of BNT162B2. The patient received the 1st dose on 07Jan2021 and the 2nd dose 18 days after on 24Jan2021. The patient reported she was a healthy individual and hasn't gone to the doctor or anything. She hasn't call out of work or anything, but she called out for work after her 2nd vaccine dose, she was out for a week. On 25Jan2021, she had a high fever (fever was 102, fluctuated from 102-103) that would not break and nausea. The fever started 12-13 hours after the vaccine which stayed at 102-103 and made her feel nauseous. The patient felt she was freezing, shaking, and burning up. She believed the body aches and nausea aches came from trembling. The patient also had the chills. The patient drank lots of fluids, had soup, and Tylenol with the high fever. These symptoms all happened at the same time and she recovered completely. On 20Mar2021, a month and a half after the patient's 2nd dose, the patient started getting symptoms after her 43rd birthday. She started to develop pain in her lower left shoulder blade. She didn't know if she pulled or twisted it wrong. The pain increased by 21Mar2021. On 24Mar2021 at work, the patient's supervisor asked why she was using a heat pack. She told her supervisor that she was having stabbing pain that was radiating around her rib cage to her left breast. The supervisor asked if it was burning and she had a rash. The patient confirmed she had no rash. It was a deep excruciating pain like someone is hitting her with a bat or stabbing her. The patient added that the pain started medially, on the inner part of her shoulder blade. She was later diagnosed with shingles. No relevant tests were performed. Therapeutic measures were taken as a result of the events shoulder blade pain and chest pain (heat pack); and fever (Tylenol). The outcome of the events shoulder blade pain and shingles was not recovered while the outcome of the events fever, nausea, chills, tremor, and burning sensation was recovered on 29Jan2021. The outcome of the remaining events was unknown.
This spontaneous report as received from a medical assistant, concerning a 4 month old female patient, with none pertinent medical history. On 15-MAR-2013 the patient received the first dose of PEDVAXHIB (lot number 0419AE, expiration date 17-AUG-2014) (dose, frequency and route were not reported). No other co suspect or concomitant medications were reported. It was reported that in March 2013 the patient developed an injection site reaction which included swelling, redness and a knot at the injection site. The patient sought unspecified medical attention. This was the 3rd of 5 reports from this office. At the time of the report the patient's outcome was recovering for all the adverse events. Additional information has been requested.
Chillblains/Pernio of the toes following administration of vaccine and possibly rituximab
child broke out w/pimple like rash starting in groin area;w/in 24hr turned into vesicles in groin then spreading to back, face & scattered vesicles over most of body;placed on Zovirax;
This spontaneous report as received from a registered nurse refers to a 6 month old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. On 28-AUG-2015, the patient was vaccinated with the third dose in series of ROTATEQ, orally, (dose, lot number and expiration date were not reported) (reported as "6 months well baby shots"). According to the reporting registered nurse, "baby spit some out and some of vaccine possibly went into patient's eye". It was reported that the patient's eye was immediately flushed and no other treatment was implemented at the time of exposure. According to the reporting nurse, there might have been 0.25 ml remaining in oral ROTATEQ tube. The nurse also stated that patient received other unspecified "6 months shots" while present in the office (on 28-AUG-2015) and that the patient's mom said the baby was doing fine. Additional information has been requested.
Patient with history of 3 COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  " patient was brought into the emergency department via EMS complaining of fall.  On arrival he had acute metabolic encephalopathy acute hypoxic respiratory failure and right hip fracture.  Ortho was consulted.  CTA ordered showed subsegmental pulmonary embolism with no evidence of right heart strain.  He was on 5 L venturi mask for respiratory support.  CPK elevated at 242.  Echo read ejection fraction 55-60%.  Ortho perform the operation for right hip hemiarthroplasty to repair in the right hip femoral neck fracture.  X-ray obtained post surgically shows surgical hardware aligned intact.  Patient continue to see PT OT following surgery for rehab.  PT recommended skilled nursing facility for continued rehab.  Following 10 days for COVID duration patient left to SNF."
Killing pain; Third dose was administered; Pain all over body feels electrocution, feels like lungs are being pulled out; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Killing pain), EXTRA DOSE ADMINISTERED (Third dose was administered), MYALGIA (Pain all over body feels electrocution, feels like lungs are being pulled out), HEADACHE (Headache) and CHILLS (Chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LITHIUM for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Aug-2021, the patient experienced PAIN (Killing pain), EXTRA DOSE ADMINISTERED (Third dose was administered), MYALGIA (Pain all over body feels electrocution, feels like lungs are being pulled out), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 16-Aug-2021, EXTRA DOSE ADMINISTERED (Third dose was administered) had resolved. At the time of the report, PAIN (Killing pain), MYALGIA (Pain all over body feels electrocution, feels like lungs are being pulled out), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.
On May 2nd liquid coming out of my breast looked like blood.  I contacted Dr. and at this time my breast was red and was diagnosed with mastitis.  Mass was found at a later sonogram.  After diagnostic mammogram and ultrasound I was diagnosed with breast cancer.  Stage 01.
Swollen arm below the injection (red)  Flu-like symptoms for  3 days after - one week after  continued to feel achy. Arm  still not back to normal. Going  on 2 weeks. Attaching copy of vaccines
Site: Itching at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypertension-Severe, Systemic: Nausea-Medium, Systemic: Vomiting-Medium
pt called next day and says she has a rash around injection site and onto her back. Rash is irregularly shaped, itchy . Pt was told to start an antihistamine and follow up if worsening.
area of skin on the right lower bicep that is warm to the touch and feels bumpy and raised; area of skin on the right lower bicep that is warm to the touch and feels bumpy and raised; tiredness; body aches; chills; fever; This case was reported by a nurse via call center representative and described the occurrence of local swelling in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 3454N, expiry date 23rd August 2022) for prophylaxis.   On 21st October 2020, the patient received the 1st dose of Shingrix (intramuscular). In October 2020, less than a day after receiving Shingrix, the patient experienced local swelling, skin warm, tiredness, general body pain, chills and fever. On an unknown date, the outcome of the local swelling, skin warm, tiredness, general body pain and chills were not recovered/not resolved and the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the local swelling, skin warm, tiredness, general body pain, chills and fever to be related to Shingrix.  Additional details were reported as follows: The patient received the first dose of Shingrix vaccine in right deltoid and within 24 hours after receiving the vaccine had a fever that lasted 2 days and resolved. Within 24 hours after receiving the vaccine, patient had chills, body aches, and tiredness and these were better but still ongoing. The patient also developed an area of skin on the right lower bicep that was warm to the touch and feels bumpy and raised, within 24 hours of receiving the vaccine and this was still ongoing. The reporter did not consent to follow-up. This is 1 of the 4 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020211991:same reporter US-GLAXOSMITHKLINE-US2020211992:same reporter US-GLAXOSMITHKLINE-US2020211994:same reporter
Information has been received from a pharmacy student concerning a 17 month old male patient with no medical history and no drug allergy/reaction who on 06-FEB-2012 was vaccinated SQ with a dose of VARIVAX (Merck) (lot # 671130/1220AA). There was no concomitant medication. On 11-APR-2012 the patient developed varicella like rash all over the body along with febrile illness after receiving VARIVAX (Merck). There was no laboratory studies performed. The patient came into the clinic to seek medical attention and was given no treatment for AEs. At the time of the report, the patient's outcome was unknown. This is one of several cases reported by the same source. A preliminary lot check investigation was performed. To date our investigation has found that this lot confirmed to quality release parameters and the manufacturing was typical of a lot of VARIVAX (Merck). Additional information will be provided upon finalization of this manufacturing investigation. Additional information has been requested.
CONFIRMED COVID19; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On 15-APR-2021, the subject experienced confirmed covid19. Laboratory data included: COVID-19 virus test positive (NR: not provided) Positive for Covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed covid19 was not reported. This report was non-serious.
Information has been received from a physician concerning a male with a history of reflux and no drug allergies who on 14-NOV-2006, 13-DEC-2006 and 30-MAR-2007 was vaccinated PO with his first, second and third dose of ROTATEQ. On 26-FEB-2008 the patient experienced vomiting, diarrhea and his stool smelled like rotavirus. Since the patient experience vomiting and diarrhea, he was moderately dehydrated. The patient sought unspecified medical attention. No labs or diagnostic studies were performed. The child was noted to be fine and subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
Rash and redness of approximately 2 inches around injection site on left arm that appeared 1 week after vaccine  Tylenol
the reaction he had was so miniscule that it was nothing more than like walking out of the door and bumping into the corner; A little soreness in arm; discomfort in his arm was so slight; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old male patient received bnt162b2 (BNT162B2), administration date 11Mar2021 09:00 (Batch/Lot number: unknown) at the age of 78 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 11Mar2021, outcome "unknown", described as "A little soreness in arm"; LIMB DISCOMFORT (non-serious) with onset 11Mar2021, outcome "recovered" (Mar2021), described as "discomfort in his arm was so slight"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "the reaction he had was so miniscule that it was nothing more than like walking out of the door and bumping into the corner".  Additional information: Caller reported that he did not know that he had any discomfort in his arm until dinner time when he was putting an item away in the cupboard. Caller was reporting on his lady friend with whom received both doses of the Pfizer COVID-19 vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No additional AE; a patient was administered PROQUAD that experienced a temperature excursion.; This spontaneous report has been received from a non health care professional and refers to a unknown patient of an unknown age and gender.  The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported.  On 23-AUG-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin [rHA]) (PROQUAD) subcutaneous injection,  as prophylaxis ( lot #W017567 confirmed to be valid, expiration date reported and stablished as 29-NOV-2023 ) (strength, dose, vaccination scheme, route of administration and anatomical location were not provided) following a temperature excursion of 3.6 degrees Celsius for 3 hours 7 minutes, it was stated that no previous temperature excursions occurred. No additional adverse event was reported.  This case was considered as non-valid due to lack of patients identifiers.  Follow-up information has been received from  a registered nurse on 15-SEP-2022, regarding a now reported as a 4-year-old male patient. His concomitant medications included diphtheria vaccine toxoid (+) pertussis vaccine acellular 3-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (GSK).  It was updated that this was the second dose (also reported as: "previous doses: 1") of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) was administered subcutaneously.
a bruise on her ankle and it split open; a bruise on her ankle it split open; soreness of her arm where she got the injection after the first dose; back spasms pain; back spasms pain; This is a spontaneous report from a contactable consumer (the patient) via the Pfizer-sponsored program. A 95-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date (at the age of 95-year-old) as single dose for COVID-19 immunization. Medical history included using a wheelchair. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced soreness of her arm where she got the injection after the first dose at 12 noon and then at 10 pm she had the pain. On an unspecified date, she had a bruise on her ankle and it split open so she put POLYSPORIN (bacitracin and polymyxin B) on it. Then she bruised it again on her wheelchair. She also reported experiencing bad back spasms pain for 3-4 days which happens periodically (unspecified date). The clinical outcomes of the soreness of her arm where she got the injection, back spasms pain and a bruise on her ankle it split open were unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
pt recv vax & w/in 24hr exp itching & urticaria;pt then devel vesicles on legs;pt was seen by MD who prescribed Medrol dosepak;sx resolved by 10APR96;
Vaccine Induced Hepatitis; liver enzymes were elevated; terrible flank pain; very cranky since the shot; nauseous; fatigue; vomiting; severe epigastric pain; urine had blood in it; sicker than a dog; A spontaneous report was received from nurse, concerning herself, a 72-year-old female patient, who received  Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue, sickness, epigastric pain, covid arm, rusty urine, vomiting, nauseous and vaccine induced hepatitis.  The patient medical history was reported as unknown. concomitant drugs were not provided.  On 4 Mar 2021, the patient received their first two of two planned doses of mRNA-1273 (Lot number: 027A21A) intramuscularly in the arm of prophylaxis of COVID-19 infection.  On 4 Mar 2021, Patient experienced fatigue, sickness, epigastric pain, rusty urine, blood I urine, vomiting, nauseous.   On 19 Mar 2021 for her annual exam and her liver enzymes were elevated, doctor states that it was vaccine induced hepatitis.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of all events were unknown.; Reporter's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
1) Initially developed severe flu-like symptoms the day following receiving the March 20 vaccination.   2) Tinnitus developed in the left ear together with ear congestion that has continues to this day.  3) Initial intense discomfort was treated for 5-days with ear drops (Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP). 4) Painful intensity abated, but laud tinnitus has continued to this day. No further treatment has been provided in hopes that the tinnitus will abate with time. Ear MRI scheduled for March 27.  5) Potential for Long Term Damage TBD
very cold and always hot; chills periodically; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
pt recv 2 doses of vax 12MAR96 & 9APR96 & 16MAY96 an antibody IgG titer was <10 which indicated that the pt was non-immune; pt on dialysis & awaiting a kidney transplant;
Patient calls with report of irregular heart rate, shortness of breath, chest congestion, sinus congestion, loss of smell.  There have been three positive COVID cases at his work. He is full vaccinated.  Reports hx of afib.
Information has been received concerning a 16 month old white male who on 01-MAR-2006 at 9:30 am was vaccinated in the deltoid with a first dose of Varivax (lot # 649738/0120R). There was no illness after vaccination. On 22-MAY-2006 at 2 pm the patient broke out in chickenpox. At the time of the report the patient had not recovered. Additional information has been requested.
Tightness of throat, tightness of chest, Tachycardia. Benadryl 50mg po given with no improvement. Epi pen IM times two with no improvement. Transported to ER.